A novel nonopioid action of enkephalins: Competitive inhibition of the mammalian brain high affinity L-proline transporter

Molecular Pharmacology

Volumn 49, Issue 6, 1996, Pages 1033-1041

  Fremeau Jr , Robert T ^a   Velaz Faircloth, Maria ^a   Miller, Joshua W ^a   Henzi, Victor A ^a   Cohen, Susan M ^a   Nadler, J Victor ^a   Shafqat, Saad ^a   Blakely, Randy D ^b   Domin, Barbara ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; GLYCYLGLYCYLPHENYLALANYLLEUCINE; LEUCINE ENKEPHALINAMIDE[DETYROSINE]; METENKEPHALIN DERIVATIVE; PROLINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG CONFORMATION; DRUG POTENCY; DRUG PROTEIN BINDING; HELA CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANIMALS; BRAIN; ENKEPHALINS; HELA CELLS; HUMANS; MALE; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; NALTREXONE; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029995838     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Beanett, J. P., W. J. Logan, and S. H. Snyder. Amino acid neurotransmitter candidates: sodium-dependent high affinity uptake by unique synaptosomal fractions. Science (Washington D. C.) 178:997-999 (1972).
2. Peterson, N. A., and E. Raghupathy. Characteristics of amino acid accumulation of synaptosomal particles isolated from rat brain. J. Neurochem. 19:1423-1438 (1972).
3. Balcar, V. J., G. A. R. Johnston, and A. L. Stephenson. Transport of L-proline by rat brain slices. Brain Res. 102:143-151 (1976).
4. Hauptmann, M., D. F. Wilson, and M. Erecinska. High affinity proline uptake in rat brain synaptosomes. FEBS Lett. 161:301-305 (1983).
5. Nadler, J. V. Sodium-dependent proline uptake in the rat hippocampal formation: association with ipsilateral commissural projections of CA3 pyramidal cells. J. Neurochem. 49:1155-1160 (1987).
6. Henzi, V., D. B. Reichling, S. W. Helm, and A. B. MacDermott. L-Proline activates glutamate and glycine receptors in cultured rat dorsal horn neurons. Mol. Pharmacol. 41:793-801 (1992).
7. Fremeau, R. T., Jr., M. G. Caron, and R. D. Blakely. Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8:915-926 (1992).
8. Shafqat, S., M. Velaz-Faircloth, V. A. Henzi, K. D. Whitney, T. L. Yang-Feng, M. F. Seldin, and R. T. Fremeau, Jr. Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes. Mol Pharmacol. 48:219-229 (1995).
9. Shafqat, S., M. Velaz-Faircloth, A. Guadano-Ferraz, and R. T. Fremeau, Jr. Molecular characterization of neurotransmitter transporters. Mol. Endocrinol. 7:1517-1529 (1993).
10. Stevens, B. R., J. D. Kaunitz, and E. M. Wright. Intestinal transport of amino acids and sugars: advances using membrane vesicles. Annu. Rev. Physiol. 46:417-433 (1984).
11. Christensen, H. N. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70:43-77 (1990).
12. Nadler, J. V., S. D. Bray, and D. A. Evenson. Autoradiographic localization of proline uptake in excitatory hippocampal pathways. Hippocampus 2:269-278 (1992).
13. Velaz-Faircloth, M. A. Guadano-Ferraz, V. A. Henzi, and R. T. Fremeau, Jr. Mammalian brain-specific L-proline transporter: neuronal localization of mRNA and enrichment of transporter protein in synaptic plasma membranes. J. Biol. Chem. 270:15755-15761 (1995).
14. Rhoads, D. E., N. E. Peterson, and E. Raghupathy. Selective inhibition of synaptosomal proline uptake by leucine and methionine enkephalins. J. Biol. Chem. 258:12233-12237 (1983).
15. Munson, P. J., and D. Rodbard. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239 (1980).
16. Hess, H. H., M. B. Lees, and J. B. Derr. A linear Lowry-Folin assay for both water soluble and sodium dodecyl sulfate-solubilized proteins. Anal. Biochem. 85:295-300 (1978).
17. Fuerst, T. R., E. Niles, F. W. Studier, and B. Moss. Eukaryotic transient expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126 (1986).
18. Giros, B., S. El Mestikawy, N. Godinot, K. Zheng, H. Han, T. Yang-Feng, and M. G. Caron. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:383-390 (1992).
19. Guastella, J., N. Nelson, H. Nelson, L. Czyzyk, S. Keynan, M. C. Miedel, N. Davidson, H, A. Lester, and B. Kanner. Cloning and expression of a rat brain GABA transporter. Science (Washington D. C.) 249:1303-1306 (1990).
20. Ramamoorthy, S., A. L. Bauman, K. R. Moore, H. Han, T. L. Yang-Feng, A. S. Chang, V. Ganapathy, and R. D. Blakely. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90:2542-2546 (1993).
21. Pacholczyk, T., R. D. Blakely, and S. G. Amara. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (Lond.) 350:350-354 (1991).
22. +-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. J. Biol. Chem. 268:8418-8421 (1993).
23. Kim, K.-M., S. F. Kingsmore, H. Han, T. L. Yang-Feng, N. Godinot, M. F. Seldin, M. G. Caron, B., and Giros. Cloning of the human glycine transporter type 1: molecular and pharmacological characterization of novel isoform variants and chromosomal localization of the gene in the human and mouse genomes. Mol. Pharmacol. 45:608-617 (1994).
24. Velaz-Faircloth, M., T. S. McGraw, M. S. Malandro, R. T. Fremeau, Jr., M. S. Kilberg, and K. J. Anderson. Characterization and distribution of the neuronal glutamate transporter EAAC1 in rat brain. Am. J. Physiol. 270:C67-C75 (1996).
25. Morley, J. S Structure-activity relationships of enkephalin-like peptides. Annu. Rev. Pharmacol. Toxicol. 20:81-110 (1980).
26. Gioannini T. L., Y. H. Yao, J. M. Hiller, L. P. Taylor, and E. J. Simon. Antisera against peptides derived from a purified μ-opioid binding protein recognizes the protein as well as μ-opioid receptors in brain regions and a cell line. Mol. Pharmacol. 44:796-801 (1993).
27. Simon, E. J., and J M. Hiller. Opioid peptides and opioid receptors, in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects (G. J. Siegel, B. Agranoff, R. W. Albers, and P. Molinoff, eds.). 4th ed. New York, NY, Raven Press, 271-285 (1989).
28. + channel-blocking peptides. Neuron 15:5-10 (1995).
29. MacKinnon, R., and C. Miller. Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor. Science (Washington D. C.) 245:1382-1385 (1989).
30. Fremeau, R. T., Jr., J. Chan, A. Pohorille, J. V. Nadler, T. A. Milner, and V. M. Pickel. Mammalian brain-specific L-proline transporter: preferential localization of transporter protein to glutamatergic nerve terminals in rat forebrain. Soc. Neurosci. Abstr. 21:2062 (1995).
31. Cohen, S. M., and J. V. Nadler. Proline-induced potentiation of synaptic transmission is long-lasting and NMDA receptor-dependent. Soc. Neurosci. Abstr. 21:1108 (1995).
32. Khachaturian, H., M. E. Lewis, M K.-H. Schafer, and S. J. Watson, S. J Anatomy of the CNS opioid systems. Trends Neurosci. 8:111-119 (1985).
33. Gall, C., N. Brecha, H. J. Karten, and K. J. Chang. Localization of enkephalin-like immunoreactivity to identified axonal and neuronal populations of the rat hippocampus. J. Comp Neurol. 198:335-350 (1981).
34. Xie, C. W., and D. V. Lewis. Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse J. Pharmacol. Exp. Ther. 256:289-296 (1991).
35. Sesack, S R., and V. M. Pickel. Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions. J. Neurosci. 12:1335-1350 (1992).
36. Viveros, O. H., E. J. Diliberto, E. Hazum, and K. J. Chang. Opiate-like materials in the adrenal medulla: evidence for storage and secretion with catecholamine. Mol. Pharmacol. 16:1101-1108 (1979).
37. Eccles, J. C., and J. C. Jaeger. The relationship between the mode of operation and the dimensions of the junctional regions at synapses and motor end-organs. Proc. R. Soc. Lond. Biol. 148:38-58 (1958).
38. Chen, L., Y. Gu, and L.-Y. Huang. The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin. J. Neurosci. 15:4602-4611 (1995).
39. Hersh, L. B., T. E. Smith, and J. F. McKelvy. Cleavage of endorphins to des-Tyr endorphins by homogeneous bovine brain aminopeptidases. Nature (Lond.) 286:160-162 (1980).
40. Johnson, J. L., and Roberts, E. Proline, glutamate, and glutamine metabolism in mouse brain synaptosomes. Brain Res. 323:247-256 (1984).